Immunotherapy drug a 'gamechanger' for head and neck cancer

Immunotherapy drug a 'gamechanger' for head and neck cancer
 

An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untreatable forms of the disease.
Nivolumab was found to extend the lives of relapsed patients diagnosed with head and neck cancers who had run out of therapy options. After a year of treatment, 36% of trial patients treated with the drug were still alive compared with 17% of those given standard chemotherapy.
Cervical cancer: gap between screenings ‘can be increased to 10 years’ Read more Patients with advanced head and neck cancers resistant to... read more

 
9 October 2016 in Health, Views: 44
Source: Guardian
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31